#53 - We’re back! News Recap and Updates from the Team
Release Date: 11/02/2022
Hamilton Morris Sued, MAGA Weirdo on Shrooms, VA Mental Health Collapse Under Trump 05.20.2026
The Psymposia Podcast
Russell, Normie, Pace and James debut a new podcast format covering the latest developments in psychedelics, drug policy, and politics. Today, they review the latest Church of Sacred Synthesis lawsuit news, misperceptions of the "psychedelic Left", Purdue Pharma’s collapse, the Trump administration's cuts to fentanyl test strip funding, vaccine and ivermectin discourse, and worsening conditions in veterans’ mental healthcare. Footnotes: Michelle Lhooq — “We Have Entered the Era of Conservative Psychedelia” Associated Press — “OxyContin maker Purdue Pharma to dissolve...
info_outline
#70 Telepathy in Psychedelic Therapy
The Psymposia Podcast
Psymposia board member Dr. Neşe Devenot’s presentation at the Ohio State University “Religion and Psychedelics” conference, recorded March 28, 2026. In this talk, Dr. Devenot presents their research on the reliance on unscientific telepathic attunement in many popular schools of psychedelic therapy.
info_outline
#69 Why is Professor Dave Promoting Psychedelic Grifters?
The Psymposia Podcast
Professor Dave is a well-known science communicator and prolific debunker of pseudoscience. Despite building his platform on combatting misinformation, he continues joining conversations that promote false claims about the FDA’s rejection of MDMA-assisted therapy — one of which he republished on his own channel. In this episode, Psymposia responds to the latest of these conversations on the Danny Jones Podcast. We encourage Professor Dave to do his homework on the psychedelic industry before aligning himself with the very pseudoscience promoters he's built his career opposing.
info_outline
#68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover
The Psymposia Podcast
Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major problems and pseudoscience within Lykos’/Resilient's trials. Update to episode #68.
info_outline
#68 A Leftist Primer on the Right-Wing Psychedelic Takeover
The Psymposia Podcast
Psychedelics are the next front in Big Tech's dystopia. Psymposia developed this primer for leftists in response to Donald Trump‘s April 18 Executive Order, which accelerates review of psychedelic drugs deemed “Breakthrough Therapies” and makes Schedule 1 drugs more accessible under Right to Try laws. This announcement made a splash in psychedelic media, where praise for the Trump administration mixes with false claims about an “end to prohibition.” In this discussion, we provide important context about this Executive Order and the people who engineered this moment behind the scenes....
info_outline
#67 Just Up the Dose?: Therapy Cults are Influencing Psychedelic Medicine Standards
The Psymposia Podcast
It has become a problematic standard practice in the psychedelic therapy industry to increase drug dosages after patients display red flag symptoms. Psymposia discusses a recent Wall Street Journal article about these practices as they manifest in the ketamine industry; the psychedelic industry’s historic normalization of these practices; and recent attempts to convince lawmakers to protect psychedelic providers from liability for standard forms of medical malpractice. Together, these developments highlight why allowing a therapy cult to influence the norms of psychedelic medicine puts the...
info_outline
#66 Hamilton's Pharma Cope, Part 4: "The Face of Psychedelic Ethics"
The Psymposia Podcast
In this final episode, we explore the attempts made by Hamilton Morris to attack the work, integrity, and character of our team.
info_outline
#65 Hamilton's Pharma Cope, Part 3: Paid Protestor Paranoia
The Psymposia Podcast
Psymposia discusses Hamilton Morris's misinformation about their funding, his relationship with Compass Pathways, his claims that the nonprofit Usona has planted protestors at conferences to make him look bad, and claims that Psymposia encouraged terrorism.
info_outline
#64 Hamilton's Pharma Cope, Part 2: Psychedelic Cult Defenders
The Psymposia Podcast
Psymposia discusses their history with the Church of Psilomethoxin and addresses Hamilton Morris's misinformation about their funding and the alleged elder abuse of psychedelic funder George Sarlo by MAPS Board Chair Vicky Dulai.
info_outline
#63 Hamilton's Pharma Cope, Part 1: "DEA Informants"
The Psymposia Podcast
Psymposia addresses Hamilton Morris's misinformation, including his speculation that they are DEA informants, their behavior at the FDA advisory committee for Lykos' Therapeutics' MDMA application, and more.
info_outlineWe’re back…mostly. In this episode we ramble about the Psychedemia conference, the serpent handler researcher who helped legitimize Johns Hopkins’ psychedelic research, Steve Jobs’ guru “Toxic Bob”, hot psilocybin patent garbage, Mind Medicine Australia’s utterly cringe appearance on ABC’s Four Corners documentary “Psyched Up”, popping psychedelic hype bubbles, and Dave’s new studio that’s covered in fractal horses.
References
Psychologist Ralph Hood’s study of serpent handling and mysticism helped legitimize the study of psychedelics. So why doesn’t he want them approved for medical use?
The Misadventures Of “Toxic Bob”
Throughout his lifetime, Robert Friedland has evolved from Steve Jobs' psychedelic guru to mining guru, leaving a trail of environmental destruction in his wake.
On Drugs Substack: Hot Psilocybin Patent Garbage
How to invalidate a psychedelic patent in 30 minutes on a Sunday afternoon.
On Drugs Substack: Three Fever Thoughts As the World Turnbulls
ABC Four Corners: Psyched Up
In Australia and overseas there's a push to make psychedelic drugs part of mainstream medicine for the treatment of trauma and other mental health conditions. Results from clinical trials are promising for PTSD sufferers where conventional treatments have failed. Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. There's now pressure in the industry to downplay the negative stories by those who stand to profit from the business of psychedelics.
Preparing for the Bursting of the Psychedelic Hype Bubble
Is the Psychedelic Therapy Bubble About to Burst?
Support the show:
☼Patreon: http://patreon.com/psymposia
☼Donate: https://www.psymposia.com/donate/
Follow:
☼Twitter: https://twitter.com/psymposia
☼Instagram: https://www.instagram.com/psymposia/
☼Facebook: https://www.facebook.com/psymposia
☼Twitch: https://www.twitch.tv/psymposia
☼Website: https://www.psymposia.com
☼Podcast: https://www.psymposia.com/plusthree
☼Newsletter: https://www.psymposia.com/subscribe/